Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2(phosphonylmethoxy)propyl]cytosine

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 5, 1999, Pages 1198-1205

  Johnson, J A ^a,c   Gangemi, J D ^a,b  

^a CLEMSON UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CIDOFOVIR; DNA POLYMERASE; PHOSPHONIC ACID DERIVATIVE; PROTEIN P21; PROTEIN P53; THYMIDINE; VIRUS DNA;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA REPLICATION; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS RESISTANCE; WART VIRUS;

EID: 0032907722     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.5.1198     Document Type: Article

References (11)

1. Bootsma, D., L. Budke, and O. Vos. 1964. Studies on synchronous division of tissue culture cells initiated by excess thymidine. Exp. Cell Res. 33:301-309.
2. Cihlar, T., and M. S. Chen. 1996. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Mol. Pharmacol. 50:1502-1510.
3. Cundy, K. C., G. Lynch, and W. A. Lee. 1997. Bioavailability and metabolism of cidofovir following topical administration to rabbits. Antiviral Res. 35: 113-122.
4. De Castro, L. M., E. R. Kern, E. De Clercq, A. Ghaffar, E. P. Mayer, P. E. Vogt, and J. D. Gangemi. 1991. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS. Antiviral Res. 16:101-114.
5. Dvorakova, H., M. Masojidkova, A. Holy, J. Balzarini, G. Andrei, R. Snoek, and E. De Clercq. 1996. Synthesis of 2′-aminomethyl derivatives of N-(2-(phosphonomethoxy)ethyl) nucleotide analogs as potential antiviral agents. J. Med. Chem. 39:3263-3268.
6. Hilderman, R. H., and M. P. Deutscher. 1976. Macromolecular synthesis in permeable liver cells. Arch. Biochem Biophys. 175:534-540.
7. Holy, A., I. Votruba, A. Merta, J. Cerny, J. Vesely, J. Vlach, K. Sediva, I. Rosenberg, M. Otmar, H. Hrebabecky, M. Travnicek, V. Vonka, R. Snoek, and E. De Clercq. 1990. Acyclic nucleotide analogs: synthesis antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Res. 13:295-311.
8. Lörincz, A. T., R. Reid, A. B. Jenson, M. D. Greenberg, W. Lancaster, and R. J. Kurman. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337.
9. Neyts, J., R. Sadler, E. De Clercq, N. Raab-Traub, and J. S. Pagano. 1998. The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res. 58:384-388.
10. Snoeck, R., W. Wellens, C. Desloovere, M. Van Ranst, L. Naesens, E. De Clercq, and L. Feenstra. 1998. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir. J. Med. Virol. 54:219-225.
11. Xiong, X., J. L. Smith, and M. S. Chen. 1997. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation. Antimicrob. Agents Chemother. 41:594-599.